Insight

Sumanta K. Pal: Interesting interplay between microbiome and HIF2 pathways

Photo from Sumanta K. Pal/X

Aug 2, 2024, 05:45

Sumanta K. Pal: Interesting interplay between microbiome and HIF2 pathways

Sumanta K. Pal shared a post by Yi Zhang et al. on X, adding:

“Interesting interplay between microbiome and HIF2 pathways.

Any implications for kidney cancer, perhaps in the context of belzutifan therapy?

Could the effect of R. torques extend beyond the gut?

Food for thought (pun intended).”

Sumanta K. Pal

Source: Sumanta K. Pal/X

Authors: Yi Zhang, Xuemei Wang, Jun Lin, Jia Liu, Kai Wang, Qixing Nie, Chuan Ye, Lulu Sun, Yanpeng Ma, Ruize Qu, Yuejian Mao, Xuguang Zhang, Hua Lu, Pengyan Xia, Dongyu Zhao, Guang Wang, Zhipeng Zhang, Wei Fu, Changtao Jiang, and Yanli Pang

Sumanta K. Pal

belzutifan cancer Changtao Jiang Chuan Ye Dongyu Zhao Guang Wang HIF2 pathways Hua Lu Jia Liu Jun Lin Kai Wang kidney cancer Lulu Sun OncoDaily Oncology Pengyan Xia Qixing Nie Ruize Qu Sumanta K. Pal Wei Fu Xuemei Wang Xuguang Zhang Yanli Pang Yanpeng Ma Yi Zhang Yuejian Mao Zhipeng Zhang

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage